VERY PREMATURE INFANTS

Clinical trials for VERY PREMATURE INFANTS explained in plain language.

Never miss a new study

Get alerted when new VERY PREMATURE INFANTS trials appear

Sign up with your email to follow new studies for VERY PREMATURE INFANTS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Trial seeks right dose to shield tiniest babies from harmful inflammation

Disease control Recruiting now

This study aims to find the safest and most effective dose of a medication called anakinra for very premature babies. It will involve 24 infants born between 24 and 28 weeks of pregnancy. Researchers will test three different doses given by IV and also explore giving it as a shot…

Matched conditions: VERY PREMATURE INFANTS

Phase: PHASE2 • Sponsor: Monash Medical Centre • Aim: Disease control

Last updated Mar 30, 2026 14:30 UTC

VERY PREMATURE INFANTS

Get alerted when new VERY PREMATURE INFANTS trials appear

Trial seeks right dose to shield tiniest babies from harmful inflammation